Skip to main
text size:
image description

Blair Wylie, MD, MPH

Maternal Fetal Health
Clinical Overview


  • Title(s)

    Director, Mass General Chorionic Villous Sampling Program

  • Department + Services

    Maternal Fetal Health

  • My Expertise

    High risk pregnancy; prenatal care; obstetric ultrasound; chorionic villous sampling; cardiac disease and pregnancy; obstetric travel medicine; Malaria and pregnancy; global maternal-fetal medicine; multiple gestation

  • Programs + Specialties

    Dr. Wylie does not regularly visit NCH but supports our patients as part of our MGH extended care team.

  • Board Certifications

    Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
    Maternal & Fetal Medicine, American Board of Obstetrics and Gynecology

Publications & Research

Dr. Wylie’s research focuses upon global maternal-fetal health with an emphasis on infections and exposures in that can adversely impact the placenta and therefore fetal growth and well being. More specifically, her two primary interests are malaria and pregnancy and, more recently, exposure to pollutants from biomass cook smoke during pregnancy. She received an Award of Research Excellence at the 2009 Society for Maternal-Fetal Medicine Annual Meeting for work she presented entitled, “Impact of biomass cook smoke exposure on birth weight in Jharkhand, India.” She collaborates with researchers at the Harvard School of Public health, Boston University’s Center for Global Health and Development, The Blantyre Malaria Project, Columbia University, and the Kintampo Health Research Center in Ghana. She is currently involved in projects in India, Malawi, Tanzania and Ghana.



Degree & Residencies

Columbia University, MPH
Harvard Medical School, MD
University of Washington, Residency
Columbia University Medical Center, HospitalsFellowship


Dr. Wylie joined the maternal-fetal medicine faculty of the Vincent Department of Obstetrics and Gynecology at MGH in the summer of 2007. She directs the Chorionic Villous Sampling program at MGH. Her clinical practice includes a mixture of prenatal diagnosis, obstetrical ultrasound, management of high-risk pregnancies, and attendance on the labor and delivery unit. Her research focuses on global maternal-fetal health and she serves on the Global Health Committee of the Society for Maternal-Fetal Medicine. She is a member of the Perinatal Infectious Disease Prevention program, which is dedicated to providing high-quality, multidisciplinary care to patients who are planning pregnancy, currently pregnant, or have recently delivered a baby, and who are living with a variety of infectious disease conditions, including HIV, hepatitis, other bacterial, viral, and fungal infections, tuberculosis and positive TB skin tests, or recent exposures to these infections.
Back to top